Library › Molecules › Approved drugs · Eye & ear
Approved drugs · Eye & ear: 50 3D models
Water, gases, sugars, nucleotides, amino acids, ions (real sizes 0.1–1 nm). Each one is a ready-made 3D model you can turn, recolour and place in a figure — open BioDioRama and type its name in the Library search.
- Dichlorphenamide — Approved medicine — ophthalmologicals, first approved 1958. C6H6Cl2N2O4S2, 305.16 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Methazolamide — Approved medicine — ophthalmologicals, first approved 1959. C5H8N4O3S2, 236.28 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Betaxolol — Approved medicine — ophthalmologicals, first approved 1985. C18H29NO3, 307.43 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Gatifloxacin — Approved medicine — ophthalmologicals, first approved 1999. C19H22FN3O4, 375.4 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Sulfacetamide — Approved medicine — ophthalmologicals, first approved 1945. C8H10N2O3S, 214.25 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Emedastine — Approved medicine — ophthalmologicals, first approved 1997. C17H26N4O, 302.42 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Apraclonidine — Approved medicine — ophthalmologicals, first approved 1987. C9H10Cl2N4, 245.11 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Guanethidine — Approved medicine — ophthalmologicals, first approved 1960. C10H22N4, 198.31 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Carteolol — Approved medicine — ophthalmologicals, first approved 1988. C16H24N2O3, 292.38 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Fluocinolone acetonide — Approved medicine — ophthalmologicals, first approved 1963. C24H30F2O6, 452.49 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Xylometazoline — Approved medicine — ophthalmologicals. C16H24N2, 244.38 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Nepafenac — Approved medicine — ophthalmologicals, first approved 2005. C15H14N2O2, 254.29 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Isoflurophate — Approved medicine — ophthalmologicals, first approved 1957. C6H14FO3P, 184.15 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Bromfenac — Approved medicine — ophthalmologicals, first approved 1997. C15H12BrNO3, 334.17 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Dibucaine — Approved medicine — otologicals, first approved 1982. C20H29N3O2, 343.47 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Vidarabine — Approved medicine — ophthalmologicals, first approved 1976. C10H13N5O4, 267.25 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Epinastine — Approved medicine — ophthalmologicals, first approved 2003. C16H15N3, 249.32 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Sulfamethizole — Approved medicine — ophthalmologicals, first approved 1953. C9H10N4O2S2, 270.34 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Proparacaine — Approved medicine — ophthalmologicals, first approved 1953. C16H26N2O3, 294.39 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Tetrahydrozoline — Approved medicine — ophthalmologicals, first approved 1979. C13H16N2, 200.28 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Metipranolol — Approved medicine — ophthalmologicals, first approved 1989. C17H27NO4, 309.41 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Brinzolamide — Approved medicine — ophthalmologicals, first approved 1998. C12H21N3O5S3, 383.52 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Diquafosol — Approved medicine — ophthalmologicals, first approved 2010. C18H26N4O23P4, 790.31 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Rifamycin — Approved medicine — otologicals, first approved 2018. C37H47NO12, 697.78 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Chloroprocaine — Approved medicine — ophthalmologicals, first approved 1955. C13H19ClN2O2, 270.76 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Fluorometholone — Approved medicine — ophthalmologicals, first approved 1972. C22H29FO4, 376.47 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Natamycin — Approved medicine — ophthalmologicals, first approved 1978. C33H47NO13, 665.73 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Travoprost — Approved medicine — ophthalmologicals, first approved 2001. C26H35F3O6, 500.55 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Loteprednol etabonate — Approved medicine — ophthalmologicals, first approved 1998. C24H31ClO7, 466.96 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Bimatoprost — Approved medicine — ophthalmologicals, first approved 2001. C25H37NO4, 415.57 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Desonide — Approved medicine — ophthalmologicals, first approved 1972. C24H32O6, 416.51 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Medrysone — Approved medicine — ophthalmologicals, first approved 1969. C22H32O3, 344.5 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Dapiprazole — Approved medicine — ophthalmologicals, first approved 1990. C19H27N5, 325.46 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Cefmenoxime — Approved medicine — otologicals, first approved 1987. C16H17N9O5S3, 511.57 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Demecarium — Approved medicine — ophthalmologicals, first approved 1959. C32H52N4O4+2, 556.79 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Levobunolol — Approved medicine — ophthalmologicals, first approved 1985. C17H25NO3, 291.39 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Dipivefrin — Approved medicine — ophthalmologicals, first approved 1980. C19H29NO5, 351.44 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Lodoxamide — Approved medicine — ophthalmologicals, first approved 1993. C11H6ClN3O6, 311.64 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Cyclopentolate — Approved medicine — ophthalmologicals, first approved 1974. C17H25NO3, 291.39 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Echothiophate — Approved medicine — ophthalmologicals, first approved 1960. C9H23NO3PS+, 256.33 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Alcaftadine — Approved medicine — ophthalmologicals, first approved 2010. C19H21N3O, 307.4 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Besifloxacin — Approved medicine — ophthalmologicals, first approved 2009. C19H21ClFN3O3, 393.85 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Homatropine — Approved medicine — ophthalmologicals. C16H21NO3, 275.35 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Dihydrostreptomycin — Approved medicine — ophthalmologicals. C21H41N7O12, 583.6 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Tafluprost — Approved medicine — ophthalmologicals, first approved 2012. C25H34F2O5, 452.54 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Lifitegrast — Approved medicine — ophthalmologicals, first approved 2016. C29H24Cl2N2O7S, 615.49 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Sulfadicramide — Approved medicine — ophthalmologicals. C11H14N2O3S, 254.31 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Latanoprostene bunod — Approved medicine — ophthalmologicals, first approved 2017. C27H41NO8, 507.62 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Lotilaner — Approved medicine — ophthalmologicals, first approved 2017. C20H14Cl3F6N3O3S, 596.76 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
- Netarsudil — Approved medicine — ophthalmologicals, first approved 2017. C28H27N3O3, 453.54 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.